Skip to content

A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals

A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04312763
Acronym
FLORA-20
Enrollment
3
Registered
2020-03-18
Start date
2020-03-06
Completion date
2025-02-20
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blindness, Acquired

Keywords

Observer-rated instrument

Brief summary

This study aims to validate an observer-rated assessment titled Functional Low-Vision Observer Rated Assessment (FLORA-20), which comprises 20 functional vision tasks commonly performed in or around a blind individual's home environment. This study shall be carried out with individuals who have an implanted visual prosthesis device. There are no new implantations or changes to the original implant or external wearables being studied or tested. Additionally, data from the study shall not be used alter standard of care or the user's treatment options.

Interventions

None listed

Sponsors

Boston Biomedical Associates
CollaboratorOTHER
Second Sight Medical Products
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
22 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* Subjects implanted with the Argus II or Orion device * Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent * Subject is able to follow instructions and comply with FLORA-20 scheduling and completion of tasks * Subject is willing to be filmed while performing the FLORA-20 tasks during the study

Exclusion criteria

* Subject is unsuitable for study participation as determined by Investigator's clinical judgment (with Sponsor's final input).

Design outcomes

Primary

MeasureTime frameDescription
Inter-observer reliabilitySingle 1 day visitIntraclass correlation coefficient (ICC) of the overall FLORA-20 scores provided by each of the assessors (in-person and remote)
Intra-observer reliabilitySingle 1 day visitICC of the overall FLORA-20 scores provided by the same assessor, assessed and re-assessed at two different time points

Secondary

MeasureTime frameDescription
Improvement in Average Performance, ON vs. OFFSingle 1 day visitPaired t-test to determine if there is a statistically significant improvement in average performance from ON vs. OFF
Clinical Meaningfulness (Effect Size)Single 1 day visitCohen's d calculation of overall FLORA-20 scores between device ON vs. OFF
Internal consistency - Cronbach's alphaSingle 1 day visitCronbach's alpha of the individual FLORA-20 task scores
Internal consistency - item-total correlationsSingle 1 day visitItem-total correlations for each FLORA-20 task

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026